Sangamo Therapeutics News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Sangamo Therapeutics Inc SGMO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 10.47 08:31:49
Open Price Low Price High Price Close Price Prev Close
more quote information »

Recent News

Date Time Source Heading
5/04/202117:39SEEKSangamo shares fall after hours as Q1 net loss widens,..
5/04/202116:10EDGARCurrent Report Filing (8-k)
5/04/202116:05SEEKSangamo Therapeutics EPS misses by $0.02, beats on revenue
5/04/202116:01BWSangamo Therapeutics Reports Recent Business Highlights and..
5/03/202117:35SEEKSangamo Therapeutics Q1 2021 Earnings Preview
5/03/202116:30BWSangamo Therapeutics Announces Participation at Upcoming..
4/27/202116:30BWSangamo Therapeutics Announces Presentations at 2021 Annual..
4/27/202116:15BWSangamo Therapeutics Announces First Quarter 2021 Conference..
4/02/202116:13EDGARProxy Statement (definitive) (def 14a)
3/25/202119:34EDGARStatement of Changes in Beneficial Ownership (4)
3/25/202108:30BWSangamo Therapeutics Announces Participation at Guggenheim..
3/19/202119:16EDGARInitial Statement of Beneficial Ownership (3)
3/17/202117:07EDGARCurrent Report Filing (8-k)
3/17/202116:30BWSangamo Announces EMA Releases Details Supporting Orphan..
3/16/202115:26TRMNWells Fargo: 2 Compelling Stocks With at Least 70% Upside..
2/24/202116:20EDGARAnnual Report (10-k)
2/24/202116:01SEEKSangamo Therapeutics EPS misses by $0.08, misses on revenue
2/24/202116:01BWSangamo Therapeutics Reports Recent Business Highlights and..
2/23/202117:35SEEKSangamo Therapeutics Q4 2020 Earnings Preview
2/18/202116:15BWSangamo Therapeutics Announces Participation at Upcoming..
2/17/202116:15BWSangamo Therapeutics Announces Fourth Quarter and Full Year..
2/11/202114:10EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202118:36EDGARInitial Statement of Beneficial Ownership (3)
2/10/202111:56EDGARAmended Statement of Ownership (sc 13g/a)
2/04/202111:43EDGARSchedule 13g
2/01/202116:05BWSangamo Therapeutics Appoints Rob Schott, MD, MPH, FACC, as..
2/01/202108:31EDGARAmended Statement of Ownership (sc 13g/a)
1/06/202116:27EDGARStatement of Changes in Beneficial Ownership (4)
1/06/202116:23EDGARCurrent Report Filing (8-k)
1/06/202116:10BWSangamo Therapeutics Announces Departure of Chief Financial..
1/05/202108:00BWSangamo Therapeutics to Present at the 39th Annual J.P...
12/15/202016:01EDGARCurrent Report Filing (8-k)
12/07/202007:33EDGARCurrent Report Filing (8-k)
12/07/202007:00BWPfizer & Sangamo Announce Updated Phase 1/2 Results Showing..
11/05/202008:00BWSangamo Therapeutics Announces Participation at Upcoming..
11/04/202016:25EDGARQuarterly Report (10-q)
11/04/202016:07EDGARCurrent Report Filing (8-k)
11/04/202016:01BWSangamo Therapeutics Reports Business Highlights and Third..
10/28/202016:15BWSangamo Therapeutics Announces Third Quarter 2020 Conference..
10/15/202006:25EDGARSecurities Registration: Employee Benefit Plan (s-8)
10/07/202006:45BWPfizer and Sangamo Dose First Participant in Phase 3 Study..
9/28/202008:30BWSangamo Therapeutics Announces Participation at Upcoming..
9/11/202018:19EDGARStatement of Changes in Beneficial Ownership (4)
9/11/202018:14EDGARInitial Statement of Beneficial Ownership (3)
9/11/202008:30BWSangamo Therapeutics Appoints Kenneth Hillan to Its Board of..
9/02/202016:15BWSangamo Therapeutics Announces Participation at Upcoming..
8/10/202008:30BWSangamo Therapeutics to Present at the 2020 Wedbush PacGrow..
8/06/202006:09EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
8/05/202017:23EDGARSecurities Registration: Employee Benefit Plan (s-8)
8/05/202016:21EDGARCurrent Report Filing (8-k)
See more news about this stock »

Your Recent History
Sangamo Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.